Background illustration for clinical trials search

Paid Clinical Trials Little Rock

Discover 471 paid clinical trials in Little Rock, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Little Rock AR, Cullman AL, Kansas City KS,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06767683

Phase2, Phase3, Recruiting

A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

for
Chronic Spontaneous Urticaria
Location: Little Rock AR, Oklahoma City OK, Sugar Land TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07219615

Phase2, Recruiting

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age

for
Chickenpox
Location: Sherwood AR, Hot Springs AR, Haughton LA, Tulsa OK,
Sponsor: GlaxoSmithKline

Sex: All

Age: 1

Code: NCT06740630

Phase3, Recruiting

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

for
Pneumococcal Disease
Location: Sherwood AR, Jonesboro AR, Fayetteville AR, Haughton LA,
Sponsor: Pfizer

Sex: All

Age: 0

Code: NCT07629440

Phase3, Recruiting

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

for
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Location: Little Rock AR, Kansas City MO, Oklahoma City OK,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 12 - 70+

Code: NCT04647227

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

for
Hematologic Disorder, Bleeding Disorder,
Location: Little Rock AR, Memphis TN, St Louis MO, Dallas TX,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 0+

Code: NCT04398628

Recruiting
New

Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Location: North Little Rock AR, Ocala FL, Westlake OH, Fresno CA,
Sponsor: Altimmune, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07795164

Phase3, Recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

for
Atopic Dermatitis
Location: North Little Rock AR, Tulsa OK, Birmingham AL, Macon GA,
Sponsor: LEO Pharma

Sex: All

Age: 0 - 11

Code: NCT06311682

Phase3, Recruiting

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: Bryant AR, Edmond OK, Oklahoma City OK, Atlanta GA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07573176

Phase3, Recruiting

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

for
Major Depressive Disorder
Location: Bryant AR, Bentonville AR, Saint Charles MO,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07076407

Phase3, Recruiting

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

for
Depressive Disorder, Major
Location: Bryant AR, Edmond OK, Fort Worth TX, Wichita Falls TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT06559306

Phase3, Recruiting

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

for
Acne Vulgaris
Location: Bryant AR, Rogers AR, Oklahoma City OK, Louisville KY,
Sponsor: Bausch Health Americas, Inc.

Sex: All

Age: 9 - 11

Code: NCT07524946

Recruiting

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic,
Location: Bryant AR, Birmingham AL, Clarksville IN,
Sponsor: Apollo Therapeutics Ltd

Sex: All

Age: 18 - 65

Code: NCT07599813

Phase2, Recruiting

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

for
Alopecia Areata
Location: Bryant AR, Frisco TX, Dallas TX, Birmingham AL,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 12 - 17

Code: NCT07133308

Phase3, Recruiting

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

for
Tardive Dyskinesia
Location: Bryant AR, Houston TX, Marietta GA, Tampa FL,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 70+

Code: NCT07365462

Phase2, Recruiting

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

for
Schizophrenia, Schizoaffective Disorder, Bipolar Disorder,
Location: Bryant AR, Austin TX, Omaha NE, Naperville IL,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT07105111

Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Hot Springs AR, Memphis TN, Shreveport LA,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for
Non-Small Cell Lung Cancer
Location: Hot Springs AR, Jonesboro AR, Tyler TX, Carterville IL,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT06767514

Phase3, Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Hot Springs AR, Bartlett TN, Jackson MS, Dallas TX,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase3, Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

for
Myelodysplastic Syndromes, Cytopenia
Location: Hot Springs AR, Memphis TN, Houston TX, Tampa FL,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT04419649

Phase2, Recruiting